ARCTURUS THERAPEUTICS HOLDINGS INC. Common Stock, Capital Shares Reserved for Future Issuance
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Common Stock, Capital Shares Reserved for Future Issuance of 5.53 million shares as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2020-11-09
- 2020-09-30: Common Stock, Capital Shares Reserved for Future Issuance 5.53M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2020-09-30 | 5.53M shares 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |